These observations are strengthened by the results of the integration-based approach for ANGPT1 and TGFβR2 expression in a larger cohort of breast cancer patients (n = 522) using datasets from TCGA which indicate that both proteins were downregulated in the half of samples (Fig. 7G). The gene discussed is ANGPT1; the disease is breast carcinoma.